Growth Metrics

Vertex Pharmaceuticals (VRTX) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.32%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 17.12%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -10.19%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 24.11%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.18%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.92%
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 24.11%
Dec 31, 2025 23.82%
Sep 30, 2025 27.49%
Jun 30, 2025 11.17%
Mar 31, 2025 10.50%
Dec 31, 2024 5.91%
Sep 30, 2024 -0.55%
Jun 30, 2024 6.99%
Mar 31, 2024 5.50%
Dec 31, 2023 4.59%
Sep 30, 2023 0.47%
Jun 30, 2023 2.03%
Mar 31, 2023 0.39%
Dec 31, 2022 1.31%
Sep 30, 2022 7.33%
Jun 30, 2022 7.72%
Mar 31, 2022 12.30%
Dec 31, 2021 14.15%
Sep 30, 2021 13.19%
Jun 30, 2021 40.21%
Mar 31, 2021 33.93%
Dec 31, 2020 28.64%
Sep 30, 2020 25.55%
Jun 30, 2020 -0.38%
Mar 31, 2020 -0.84%
Dec 31, 2019 -8.24%
Sep 30, 2019 -9.26%
Jun 30, 2019 -10.39%
Mar 31, 2019 -7.26%
Dec 31, 2018 2.86%
Sep 30, 2018 6.37%
Jun 30, 2018 10.25%
Mar 31, 2018 13.03%
Dec 31, 2017 13.04%
Sep 30, 2017 10.52%
Jun 30, 2017 7.17%
Mar 31, 2017 2.59%
Dec 31, 2016 0.09%
Sep 30, 2016 -2.70%
Jun 30, 2016 -3.19%
Mar 31, 2016 -2.55%
Dec 31, 2015 -2.53%
Sep 30, 2015 -1.97%
Jun 30, 2015 -2.28%
Mar 31, 2015 -2.42%
Dec 31, 2014 2.71%
Sep 30, 2014 11.09%
Jun 30, 2014 25.49%
Mar 31, 2014 44.02%
Dec 31, 2013 60.72%
Sep 30, 2013 422.70%
Jun 30, 2013 113.43%
Mar 31, 2013 196.03%
Dec 31, 2012 225.59%
Sep 30, 2012 22.59%
Mar 31, 2012 140.32%
Dec 31, 2011 84.12%
Sep 30, 2011 54.75%
Mar 31, 2011 21.97%
Dec 31, 2010 16.14%